Physician

Sarah Yagerman, MD

According to 2025 Medicare claims, Sarah Yagerman, MD (NPI: 1568873628) practices micrographic dermatologic surgery in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is UPPER WEST SIDE DERMATOLOGY, P.C. (NPI: 1427270727; TIN: 208792077) and primary practice location at 10023-2605. Yagerman is affiliated with the HHC ACO Inc (ACO ID: A1675), participating under the MSSP model.

Yagerman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 613 traditional Medicare patients, billed 2,746 HCPCS/CPT codes, and received $391,111 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 661 prescription claims across 321 beneficiaries totaling $138,480 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 63 records totaling $1,533. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $58,139 to $391,111. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $43,217 and ending at $138,480. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$196K$391K2020 Medicare payment: $58,139 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $253,448 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $290,260 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $332,773 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $391,111 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020193843$58,139
20214291,966$253,448
20225252,162$290,260
20235932,577$332,773
20246132,746$391,111

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$102K$204K2015 Drug cost: $43,217 (USD; Tot_Drug_Cst)2016 Drug cost: $16,933 (USD; Tot_Drug_Cst)2017 Drug cost: $79,524 (USD; Tot_Drug_Cst)2018 Drug cost: $69,225 (USD; Tot_Drug_Cst)2019 Drug cost: $1,241 (USD; Tot_Drug_Cst)2020 Drug cost: $9,560 (USD; Tot_Drug_Cst)2021 Drug cost: $19,583 (USD; Tot_Drug_Cst)2022 Drug cost: $83,023 (USD; Tot_Drug_Cst)2023 Drug cost: $204,274 (USD; Tot_Drug_Cst)2024 Drug cost: $138,480 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015116253$43,217
201676200$16,933
201765152$79,524
201848108$69,225
20192143$1,241
2020136241$9,560
2021208358$19,583
2022254464$83,023
2023322647$204,274
2024321661$138,480

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks150175$587
11102Biopsy of related skin growth, first growth130145$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more301429$71
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more139190$47
17000Destruction of precancer skin growth, 1 growth192258$46

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab11308$41,916
AcitretinAcitretin20684$2,827
Clobetasol PropionateClobetasol Propionate441,237$1,792
Gentamicin SulfateGentamicin Sulfate431,088$1,458
KetoconazoleKetoconazole782,205$1,126

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.63$1,533Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sarah Yagerman, MD?

Tedicare shows public-source Medicare data for Sarah Yagerman, MD (NPI 1568873628), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Yagerman, MD have ACO affiliation data?

Sarah Yagerman, MD is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675).

What billing organization is linked to Sarah Yagerman, MD?

Sarah Yagerman, MD is linked to UPPER WEST SIDE DERMATOLOGY, P.C. (billing NPI 1427270727) in the available physician profile data.

Does Sarah Yagerman, MD have Open Payments data?

Sarah Yagerman, MD has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.